Kyowa Kirin Co., Ltd. (KYKOF)
USD 16.05
(0.0%)
USD 16.05
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 244.58 Billion JPY | -1.88% |
| 2022 | 229.08 Billion JPY | 12.69% |
| 2021 | 203.28 Billion JPY | 13.62% |
| 2020 | 178.92 Billion JPY | 4.74% |
| 2019 | 170.82 Billion JPY | 1.44% |
| 2018 | 168.39 Billion JPY | 3.88% |
| 2017 | 162.11 Billion JPY | -8.33% |
| 2016 | 176.84 Billion JPY | -2.63% |
| 2015 | 181.62 Billion JPY | 7.01% |
| 2014 | 169.72 Billion JPY | 5.43% |
| 2013 | 160.98 Billion JPY | 2.03% |
| 2012 | 157.78 Billion JPY | 39.76% |
| 2011 | 112.89 Billion JPY | 5.78% |
| 2010 | 106.73 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 105.52 Billion JPY | 4.77% |
| 2007 | 100.72 Billion JPY | -0.71% |
| 2006 | 101.44 Billion JPY | 2.88% |
| 2005 | 98.6 Billion JPY | -3.96% |
| 2004 | 102.67 Billion JPY | -6.87% |
| 2003 | 110.23 Billion JPY | 1.71% |
| 2002 | 108.38 Billion JPY | 2.03% |
| 2001 | 106.23 Billion JPY | 0.97% |
| 2000 | 105.21 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 60.5 Billion JPY | -2.29% |
| 2024 Q2 | 65.99 Billion JPY | 14.02% |
| 2023 Q4 | 61.92 Billion JPY | 13.82% |
| 2023 FY | 224.77 Billion JPY | -1.88% |
| 2023 Q1 | 58.4 Billion JPY | -13.68% |
| 2023 Q3 | 54.4 Billion JPY | -5.68% |
| 2023 Q2 | 57.67 Billion JPY | -1.25% |
| 2022 FY | 229.08 Billion JPY | 12.69% |
| 2022 Q3 | 57.05 Billion JPY | 4.37% |
| 2022 Q4 | 67.66 Billion JPY | 18.6% |
| 2022 Q1 | 49.69 Billion JPY | -15.69% |
| 2022 Q2 | 54.66 Billion JPY | 10.0% |
| 2021 Q3 | 50.59 Billion JPY | 1.4% |
| 2021 FY | 203.28 Billion JPY | 13.62% |
| 2021 Q1 | 43.84 Billion JPY | -18.44% |
| 2021 Q2 | 49.9 Billion JPY | 13.81% |
| 2021 Q4 | 58.94 Billion JPY | 16.5% |
| 2020 Q2 | 40.8 Billion JPY | -1.69% |
| 2020 Q3 | 42.86 Billion JPY | 5.05% |
| 2020 Q4 | 53.75 Billion JPY | 25.42% |
| 2020 Q1 | 41.5 Billion JPY | -15.43% |
| 2020 FY | 178.92 Billion JPY | 4.74% |
| 2019 Q3 | 41.56 Billion JPY | -0.08% |
| 2019 Q1 | 38.59 Billion JPY | -19.71% |
| 2019 FY | 170.82 Billion JPY | 1.44% |
| 2019 Q2 | 41.59 Billion JPY | 7.79% |
| 2019 Q4 | 49.07 Billion JPY | 18.08% |
| 2018 Q2 | 41.85 Billion JPY | 7.61% |
| 2018 FY | 168.39 Billion JPY | 3.88% |
| 2018 Q4 | 48.06 Billion JPY | 21.45% |
| 2018 Q3 | 39.57 Billion JPY | -5.45% |
| 2018 Q1 | 38.89 Billion JPY | 10.48% |
| 2017 Q4 | 35.2 Billion JPY | -8.93% |
| 2017 Q3 | 38.65 Billion JPY | -4.22% |
| 2017 FY | 162.11 Billion JPY | -8.33% |
| 2017 Q2 | 40.36 Billion JPY | -1.94% |
| 2017 Q1 | 41.16 Billion JPY | -13.98% |
| 2016 Q3 | 40.51 Billion JPY | -10.55% |
| 2016 Q1 | 43.19 Billion JPY | -17.06% |
| 2016 Q4 | 47.84 Billion JPY | 18.11% |
| 2016 FY | 176.84 Billion JPY | -2.63% |
| 2016 Q2 | 45.29 Billion JPY | 4.84% |
| 2015 Q2 | 43.81 Billion JPY | 2.9% |
| 2015 FY | 181.62 Billion JPY | 7.01% |
| 2015 Q4 | 52.08 Billion JPY | 20.72% |
| 2015 Q3 | 43.14 Billion JPY | -1.52% |
| 2015 Q1 | 42.57 Billion JPY | -13.84% |
| 2014 Q2 | 40.95 Billion JPY | 5.43% |
| 2014 Q4 | 49.41 Billion JPY | 22.0% |
| 2014 FY | 169.72 Billion JPY | 5.43% |
| 2014 Q3 | 40.5 Billion JPY | -1.1% |
| 2014 Q1 | 38.84 Billion JPY | -13.92% |
| 2013 Q3 | 37.87 Billion JPY | -5.53% |
| 2013 Q2 | 40.08 Billion JPY | 5.79% |
| 2013 FY | 160.98 Billion JPY | 2.03% |
| 2013 Q1 | 37.89 Billion JPY | -67.06% |
| 2013 Q4 | 45.12 Billion JPY | 19.16% |
| 2012 Q3 | 14.56 Billion JPY | 3.3% |
| 2012 Q2 | 14.09 Billion JPY | -0.01% |
| 2012 FY | 157.78 Billion JPY | 39.76% |
| 2012 Q1 | 14.09 Billion JPY | -80.17% |
| 2012 Q4 | 115.02 Billion JPY | 689.97% |
| 2011 Q1 | 13.25 Billion JPY | -80.28% |
| 2011 Q3 | 14.72 Billion JPY | 6.61% |
| 2011 Q2 | 13.81 Billion JPY | 4.19% |
| 2011 FY | 112.89 Billion JPY | 5.78% |
| 2011 Q4 | 71.09 Billion JPY | 382.73% |
| 2010 Q1 | 11.38 Billion JPY | 0.0% |
| 2010 Q3 | 13.33 Billion JPY | -9.75% |
| 2010 Q4 | 67.23 Billion JPY | 404.01% |
| 2010 Q2 | 14.78 Billion JPY | 29.84% |
| 2010 FY | 106.73 Billion JPY | 0.0% |
| 2009 Q2 | 11.67 Billion JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q3 | 12.67 Billion JPY | 8.49% |
| 2008 Q2 | 16.67 Billion JPY | 0.0% |
| 2008 Q3 | 14 Billion JPY | -15.99% |
| 2008 FY | 105.52 Billion JPY | 4.77% |
| 2007 FY | 100.72 Billion JPY | -0.71% |
| 2006 FY | 101.44 Billion JPY | 2.88% |
| 2005 FY | 98.6 Billion JPY | -3.96% |
| 2004 FY | 102.67 Billion JPY | -6.87% |
| 2003 FY | 110.23 Billion JPY | 1.71% |
| 2002 FY | 108.38 Billion JPY | 2.03% |
| 2001 FY | 106.23 Billion JPY | 0.97% |
| 2000 FY | 105.21 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AstraZeneca PLC | 29.57 Billion USD | -726.922% |
| Bristol-Myers Squibb Company PFD CONV 2 | 17.07 Billion USD | -1332.763% |
| CSPC Pharmaceutical Group Limited | 2.14 Billion USD | -11292.238% |
| Clarus Therapeutics Holdings, Inc. | 50.96 Million USD | -479774.041% |
| Novartis AG | 24.87 Billion USD | -883.422% |
| PT Kalbe Farma Tbk. | 11823.24 Billion USD | 97.931% |